Endocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Pediatric Endocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
J Clin Endocrinol Metab. 2020 Apr 1;105(4):e1648-56. doi: 10.1210/clinem/dgz221.
Skeletal fragility is a significant complication of type 1 diabetes (T1D), with an increased risk of fracture observed starting in childhood. Altered bone accrual and microarchitectural development during the critical peripubertal years may contribute to this fragility.
To evaluate differences in skeletal microarchitecture between girls with T1D and controls and to assess factors associated with these differences.
Cross-sectional comparison.
Girls ages 10-16 years, 62 with T1D and 61 controls.
Areal bone mineral density (BMD) measured by dual-energy x-ray absorptiometry did not differ between girls with and without T1D. At the distal tibia, trabecular BMD was 7.3 ± 2.9% lower in T1D (P = 0.013), with fewer plate-like and axially-aligned trabeculae. Cortical porosity was 21.5 ± 10.5% higher, while the estimated failure load was 4.7 ± 2.2% lower in T1D (P = 0.043 and P = 0.037, respectively). At the distal radius, BMD and microarchitecture showed similar differences between the groups but did not reach statistical significance. After stratifying by HbA1c, only those girls with T1D and HbA1c > 8.5% differed significantly from controls. P1NP, a marker of bone formation, was lower in T1D while CTX and TRAcP5b, markers of bone resorption and osteoclast number, respectively, did not differ. The insulin-like growth factor 1 (IGF-1) Z-score was lower in T1D, and after adjustment for the IGF-1 Z-score, associations between T1D status and trabecular microarchitecture were largely attenuated.
Skeletal microarchitecture is altered in T1D early in the course of disease and among those with higher average glycemia. Suppressed bone formation and lower circulating IGF-1 likely contribute to this phenotype.
1 型糖尿病(T1D)患者存在骨骼脆弱,骨折风险增加,这一现象在儿童时期就已观察到。在关键的青春期,骨骼积累和微观结构发育的改变可能导致这种脆弱性。
评估 T1D 女孩与对照组之间骨骼微观结构的差异,并评估这些差异的相关因素。
横断面比较。
年龄在 10-16 岁的女孩,62 名患有 T1D,61 名对照。
双能 X 射线吸收法测量的面积骨密度(BMD)在 T1D 女孩和无 T1D 女孩之间没有差异。在胫骨远端,T1D 患者的骨小梁 BMD 低 7.3±2.9%(P=0.013),板状和轴向排列的骨小梁较少。皮质孔隙率高 21.5±10.5%,而估计的失效负荷低 4.7±2.2%(分别为 P=0.043 和 P=0.037)。在桡骨远端,BMD 和微观结构在两组之间也存在类似的差异,但没有达到统计学意义。根据 HbA1c 分层后,只有 HbA1c>8.5%的 T1D 女孩与对照组有显著差异。骨形成标志物 P1NP 在 T1D 中较低,而骨吸收标志物 CTX 和破骨细胞数量标志物 TRAcP5b 则没有差异。胰岛素样生长因子 1(IGF-1)Z 评分在 T1D 中较低,并且在调整 IGF-1 Z 评分后,T1D 状态与骨小梁微观结构之间的关联在很大程度上减弱。
T1D 患者在疾病早期和平均血糖较高的患者中,骨骼微观结构发生改变。骨形成受抑制和循环 IGF-1 水平降低可能导致这种表型。